DE3369640D1 - Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain - Google Patents

Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Info

Publication number
DE3369640D1
DE3369640D1 DE8383109401T DE3369640T DE3369640D1 DE 3369640 D1 DE3369640 D1 DE 3369640D1 DE 8383109401 T DE8383109401 T DE 8383109401T DE 3369640 T DE3369640 T DE 3369640T DE 3369640 D1 DE3369640 D1 DE 3369640D1
Authority
DE
Germany
Prior art keywords
brain
improvement
treatment
pharmaceutical composition
composition useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383109401T
Other languages
German (de)
English (en)
Inventor
Shizuo Kuriyama
Mikio Saitoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Mitsubishi Chemical Industries Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3369640D1 publication Critical patent/DE3369640D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8383109401T 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain Expired DE3369640D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57165546A JPS5955829A (ja) 1982-09-22 1982-09-22 脳内の器質性障害に起因する精神機能症状の改善・治療剤

Publications (1)

Publication Number Publication Date
DE3369640D1 true DE3369640D1 (en) 1987-03-12

Family

ID=15814427

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383109401T Expired DE3369640D1 (en) 1982-09-22 1983-09-21 Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain

Country Status (5)

Country Link
US (2) US4507322A (enExample)
EP (1) EP0103897B1 (enExample)
JP (1) JPS5955829A (enExample)
DE (1) DE3369640D1 (enExample)
IT (1) IT1169837B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2506376B2 (ja) * 1987-07-16 1996-06-12 三菱化学株式会社 ２−（４−メチルアミノブトキシ）ジフェニルメタン・塩酸塩の製造方法
CA2153605A1 (en) 1994-07-12 1996-01-13 Akihiro Tobe Treatment of hyperkinetic disorders
US5547993A (en) * 1995-10-24 1996-08-20 Mitsubishi Chemical Corporation Therapeutic agent for glaucoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2315913A1 (fr) * 1975-06-19 1977-01-28 Mitsubishi Chem Ind 1-(omega-aminoalcoxy)-benzenes substitues en position 2 pharmaceutiquement actifs
JPS606349B2 (ja) * 1975-09-10 1985-02-18 三菱化成工業株式会社 ２―（ω‐アミノアルコキシ）ジフエニルメタン類

Also Published As

Publication number Publication date
IT1169837B (it) 1987-06-03
JPH0233689B2 (enExample) 1990-07-30
IT8322949A0 (it) 1983-09-21
US4576966A (en) 1986-03-18
EP0103897A1 (en) 1984-03-28
US4507322A (en) 1985-03-26
EP0103897B1 (en) 1987-02-04
JPS5955829A (ja) 1984-03-31

Similar Documents

Publication Publication Date Title
GB2208476B (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
GB2096468B (en) Improvement in or relating to an apparatus for medical treatment
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
EP0242328A3 (en) Pharmaceutical composition for treating inflammation in the eye
JPS5791915A (en) Novel lipid composition useful for dietetics, resuscitation and treatment
GB9014817D0 (en) Improvements in or relating to apparatus for use in the treatment of spinal disorders
IT8548055A0 (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
IL68292A0 (en) Pharmaceutical compositions containing dihydropyridines and their use for the treatment of animals
PT76247A (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
PH24723A (en) Device and composition for treatment of the gums
GB2131293B (en) Composition containing dextran for use in medical treatment
PT73286A (en) Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
DE3369296D1 (en) Device for the examination and post treatment of articles
IT1169837B (it) Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello
JPS53130440A (en) Novel pharmaceutical composition having obuect to treat especially functional disorder of brain
IL94402A0 (en) Pharmaceutical compositions containing imidazodiazepines for the treatment of neurological symptoms
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
DE3366025D1 (en) Medicine for the treatment of the neoplazic disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: EISAI CO., LTD. MITSUBISHI KASEI CORP., TOKIO/TOKY

8339 Ceased/non-payment of the annual fee